linear regression plots graphpad prism 7 Search Results


4-parameter non-linear regression equation using graphpad prism 7.05 software  (GraphPad Software Inc)
90
GraphPad Software Inc 4-parameter non-linear regression equation using graphpad prism 7.05 software
4 Parameter Non Linear Regression Equation Using Graphpad Prism 7.05 Software, supplied by GraphPad Software Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/4-parameter non-linear regression equation using graphpad prism 7.05 software/product/GraphPad Software Inc
Average 90 stars, based on 1 article reviews
4-parameter non-linear regression equation using graphpad prism 7.05 software - by Bioz Stars, 2026-03
90/100 stars
  Buy from Supplier
deming linear regression graphpad prism 7.00  (GraphPad Software Inc)
90
GraphPad Software Inc deming linear regression graphpad prism 7.00
Detection of adalimumab and infliximab with the bioluminescence reader. Luminescence over time with (a) infliximab dRAPPID or (b) adalimumab dRAPPID sensor (10 nM LB with 20 nM SB). Blue-to-green ratios of (c) infliximab and (d) adalimumab captured with the reader (15 minutes of incubation) in buffer. Detection of (e) infliximab and (f) adalimumab in patient serum samples with dRAPPID in combination with the bioluminescence reader. The black lines in (e) and (f) represent <t>Deming</t> <t>linear</t> regression. Vertical dotted lines connects duplicate measurements of one patient sample. Values in (a) and (b) depict mean ± s.d. of technical replicates and data points in (c) and (d) represent technical replicates, with n = 3 independent preparations of target antibody.
Deming Linear Regression Graphpad Prism 7.00, supplied by GraphPad Software Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/deming linear regression graphpad prism 7.00/product/GraphPad Software Inc
Average 90 stars, based on 1 article reviews
deming linear regression graphpad prism 7.00 - by Bioz Stars, 2026-03
90/100 stars
  Buy from Supplier
non-linear regression with a one-phase association model graphpad prism 7  (GraphPad Software Inc)
90
GraphPad Software Inc non-linear regression with a one-phase association model graphpad prism 7
Detection of adalimumab and infliximab with the bioluminescence reader. Luminescence over time with (a) infliximab dRAPPID or (b) adalimumab dRAPPID sensor (10 nM LB with 20 nM SB). Blue-to-green ratios of (c) infliximab and (d) adalimumab captured with the reader (15 minutes of incubation) in buffer. Detection of (e) infliximab and (f) adalimumab in patient serum samples with dRAPPID in combination with the bioluminescence reader. The black lines in (e) and (f) represent <t>Deming</t> <t>linear</t> regression. Vertical dotted lines connects duplicate measurements of one patient sample. Values in (a) and (b) depict mean ± s.d. of technical replicates and data points in (c) and (d) represent technical replicates, with n = 3 independent preparations of target antibody.
Non Linear Regression With A One Phase Association Model Graphpad Prism 7, supplied by GraphPad Software Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/non-linear regression with a one-phase association model graphpad prism 7/product/GraphPad Software Inc
Average 90 stars, based on 1 article reviews
non-linear regression with a one-phase association model graphpad prism 7 - by Bioz Stars, 2026-03
90/100 stars
  Buy from Supplier
non-linear regression curvefitting software graphpad prism 7.01  (GraphPad Software Inc)
90
GraphPad Software Inc non-linear regression curvefitting software graphpad prism 7.01
Detection of adalimumab and infliximab with the bioluminescence reader. Luminescence over time with (a) infliximab dRAPPID or (b) adalimumab dRAPPID sensor (10 nM LB with 20 nM SB). Blue-to-green ratios of (c) infliximab and (d) adalimumab captured with the reader (15 minutes of incubation) in buffer. Detection of (e) infliximab and (f) adalimumab in patient serum samples with dRAPPID in combination with the bioluminescence reader. The black lines in (e) and (f) represent <t>Deming</t> <t>linear</t> regression. Vertical dotted lines connects duplicate measurements of one patient sample. Values in (a) and (b) depict mean ± s.d. of technical replicates and data points in (c) and (d) represent technical replicates, with n = 3 independent preparations of target antibody.
Non Linear Regression Curvefitting Software Graphpad Prism 7.01, supplied by GraphPad Software Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/non-linear regression curvefitting software graphpad prism 7.01/product/GraphPad Software Inc
Average 90 stars, based on 1 article reviews
non-linear regression curvefitting software graphpad prism 7.01 - by Bioz Stars, 2026-03
90/100 stars
  Buy from Supplier

Image Search Results


Detection of adalimumab and infliximab with the bioluminescence reader. Luminescence over time with (a) infliximab dRAPPID or (b) adalimumab dRAPPID sensor (10 nM LB with 20 nM SB). Blue-to-green ratios of (c) infliximab and (d) adalimumab captured with the reader (15 minutes of incubation) in buffer. Detection of (e) infliximab and (f) adalimumab in patient serum samples with dRAPPID in combination with the bioluminescence reader. The black lines in (e) and (f) represent Deming linear regression. Vertical dotted lines connects duplicate measurements of one patient sample. Values in (a) and (b) depict mean ± s.d. of technical replicates and data points in (c) and (d) represent technical replicates, with n = 3 independent preparations of target antibody.

Journal: Sensors & Diagnostics

Article Title: Point-of-care therapeutic drug monitoring of tumour necrosis factor-α inhibitors using a single step immunoassay †

doi: 10.1039/d3sd00131h

Figure Lengend Snippet: Detection of adalimumab and infliximab with the bioluminescence reader. Luminescence over time with (a) infliximab dRAPPID or (b) adalimumab dRAPPID sensor (10 nM LB with 20 nM SB). Blue-to-green ratios of (c) infliximab and (d) adalimumab captured with the reader (15 minutes of incubation) in buffer. Detection of (e) infliximab and (f) adalimumab in patient serum samples with dRAPPID in combination with the bioluminescence reader. The black lines in (e) and (f) represent Deming linear regression. Vertical dotted lines connects duplicate measurements of one patient sample. Values in (a) and (b) depict mean ± s.d. of technical replicates and data points in (c) and (d) represent technical replicates, with n = 3 independent preparations of target antibody.

Article Snippet: Deming linear regression (GraphPad Prism 7.00) was applied to determine the relationship between the mean results with the bioluminescence reader dRAPPID and the ELISA.

Techniques: Incubation